Phoenix Molecular Designs is a clinical-stage biotechnology company that is developing small molecule kinase inhibitors as a targeted therapy for cancer. We are focused on treating one of the most aggressive types of breast cancer, Triple Negative Breast Cancer (TNBC), which currently has limited durable options. Our patented cancer compounds position us in the lead to fast track our product to market as it fills an unmet medical need. Our cancer therapy has the potential to save lives and improve quality of life.
View Top Employees from Phoenix Molecular Designs| Website | http://phoenixmd.ca/ |
| Revenue | $9 million |
| Funding | $12 million |
| Employees | 11 (6 on RocketReach) |
| Founded | 2012 |
| Address | 3210 Merryfield Road, San Diego, California 92121, US |
| Phone | (604) 674-1796 |
| Technologies |
JavaScript,
HTML,
Twitter
+15 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Business Services General, Drug Discovery, Business Services, Science and Engineering, Therapeutics, Health Care |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Phoenix Molecular Designs employee's phone or email?
Phoenix Molecular Designs Questions
The Phoenix Molecular Designs annual revenue was $9 million in 2024.
Leena Das-Young is the Independent Board Member of Phoenix Molecular Designs.
6 people are employed at Phoenix Molecular Designs.
Phoenix Molecular Designs is based in San Diego, California.
The NAICS codes for Phoenix Molecular Designs are [3254, 32541, 32, 325].
The SIC codes for Phoenix Molecular Designs are [28, 283].
Top Phoenix Molecular Designs Employees
-
33
-
25+
-
33
-
33
-
ViewAarthi Jayanthan
Chief Operating Officer at Phoenix Molecular Designs
Vancouver, British Columbia, Canada1
Related Companies
